Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
honey is a natural functional food used in control cardiovascular risk factors but its effect on fatty liver is not investigated
Forty fatty liver (non-alcoholic from) patients with obesity are included to be divided into group 1 who will contain 20 patients who will receive honey intake (orally, as a daily total dose of 2 g/kg, this dose will be divided to three equal subdoses, every dose will be administered before meal), low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks. Group 2 who will contain 20 patients who will receive low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| honey intake and lifestyle changes | Experimental | Twenty fatty liver (non-alcoholic from) patients with obesity are included as 20 patients who will receive honey intake (orally, as a daily total dose of 2 g/kg, this dose will be divided to three equal subdoses, every dose will be administered before meal), low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks. |
|
| lifestyle changes | Active Comparator | Twenty fatty liver (non-alcoholic from) patients with obesity are included as 20 patients who will receive low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| honey intake and lifestyle changes | Behavioral | Twenty fatty liver (non-alcoholic from) patients with obesity are included as 20 patients who will receive natural unprocessed honey intake (orally, as a daily total dose of 2 g/kg, this dose will be divided to three equal subdoses, every dose will be administered before meal), low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks. |
| Measure | Description | Time Frame |
|---|---|---|
| High density lipoprotein | it will be measured in serum | it will be assessed after 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| triglycerides | it will be measured in serum | it will be assessed after 12 weeks |
| cholesterol | it will be measured in serum | it will be assessed after 12 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
based on self-representation of gender identity
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ali MA Isamil, Lecturer | Contact | 0201005154209 | ali.mohamed@pt.cu.edu.eg | |
| Alshaymaa S Abd El-Azeim, Lecturer | Contact | 021033771553 | Shimaashaaban30@yahoo.com |
| Name | Affiliation | Role |
|---|---|---|
| Ali MA Ismail, lecturer | Cairo University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| faculty of physical therapy Cairo university | Recruiting | Dokki | Giza Governorate | Egypt |
Not provided
| ID | Term |
|---|---|
| D065626 | Non-alcoholic Fatty Liver Disease |
| ID | Term |
|---|---|
| D005234 | Fatty Liver |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| lifestyle changes | Behavioral | Twenty fatty liver (non-alcoholic from) patients with obesity are included as 20 patients who will receive low calorie diet and treadmill walking (40 minutes per session, three times per week) for 12 weeks. |
|
| low density lipoprotein | it will be measured in serum | it will be assessed after 12 weeks |
| alanine transamianse | it will be measured in serum | it will be assessed after 12 weeks |
| aspartate transamianse | it will be measured in serum | it will be assessed after 12 weeks |
| fasting blood glucose | it will be measured in serum | it will be measured after 12 weeks |
| body mass index | it will be measured on empty stomach | it will be measured after 12 weeks |
| waist circumference | it will be measured on empty stomach | it will be measured after 12 weeks |